Pulmonary function test abnormalities in the elderly with systolic heart failure

Kardiologia Polska

Volumn 65, Issue 8, 2007, Pages 875-880

  Kurzawa, Rafał ^a   Baron, Tomasz ^a   Grodzicki, Tomasz ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Elderly; Heart failure; Spirometry

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; FORCED EXPIRATORY VOLUME; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERTENSION; LUNG FUNCTION TEST; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; SEX RATIO; SMOKING; SPIROMETRY; STATISTICAL SIGNIFICANCE; SYSTOLIC HEART FAILURE;

EID: 35348953673     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Remme WJ, Swedberg K; Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22: 1527-60.
2. nd ed. W.B. Saunders, Philadelphia 1985.
3. Murray JF, Nadel JA (eds.). Textbook of respiratory medicine. W.B. Saunders, Philadelphia 1996.
4. Said SI (ed.). The Pulmonary Circulation and Acute Lung Injury. Futura. Mount Kisko, NY 1985.
5. Weibel ER. The Pathway for Oxygen: Structure and Function the Mammalian Respiratory System. Harvard University Press. Cambridge, MA 1984.
6. Griffith KA, Sherrill DL, Siegel EM, et al. Predictors of loss of lung function in the elderly: the Cardiovascular Health Study. Am J Respir Crit Care Med 2001; 163: 61-8.
7. Winter UJ, Gitt AK, Blaum M, et al. Cardiopulmonary capacity in patients with coronary heart disease. Z Kardiol 1994; 83 Suppl 3: 73-82.
8. Ricart S, Casan P, Bellido-Casado J, et al. Lung function in cardiac dysfunction. Arch Bronconeumol 2004; 40: 62-6.
9. Witte KK, Morice A, Clark AL, et al. Airway resistance in chronic heart failure measured by impulse oscillometry. J Card Fail 2002; 8: 225-31.
10. Hughes PD, Polkey MI, Harrus ML, et al. Diaphragm strength in chronic heart failure. Am J Respir Crit Care Med 1999; 160: 529-34.
11. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 5-40.
12. Waxman AB. Pulmonary function test abnormalities in pulmonary vascular disease and chronic heart failure. Clin Chest Med 2001; 22: 751-8.
13. Dimopoulou I, Daganou M, Tsintzas OK, et al. Effects of severity of long-standing congestive heart failure on pulmonary function. Respir Med 1998; 92: 1321-5.
14. Evans SA, Kinnear WJ, Watson L, et al. Breathlessness and exercise capacity in heart failure: the role of bronchial obstruction and responsiveness. Int J Cardiol 1996; 57: 233-40.
15. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2006. Available from: http://www.goldcopd.org.
16. Grosgurin O, Bria A, Gaspoz JM. Beta-blockers and obstructive pulmonary diseases: such an odd couple? Rev Med Suisse 2006; 2: 285-8.
17. Salpeter S, Ormiston T, Salpeter E. Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005; (4): CD003566.
18. Boros PW, Franczuk M, Wesołowski S. Zasady interpretacji wyników badania spirometrycznego. Pneumonol Alergol Pol 2004; 72 (Supl. 2): 19-28.
19. Gondorowicz K, Sergiejko Z. Procedury wykonywania badań. Akceptowalność i powtarzalność pomiarów. Pneumonol Alergol Pol 2004; 72 (Supl. 2): 16-8.
20. Kowalski J, Koziorowski A, Radwan L. Ocena czynności płuc w chorobach układu oddechowego. Wydawnictwo Borgis, Warszawa 2004.